Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates

Financial Performance - Quanterix Corporation reported a quarterly loss of $0.25 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.23, and compared to a loss of $0.16 per share a year ago, indicating an earnings surprise of -8.70% [1] - The company posted revenues of $34.38 million for the quarter ended June 2024, surpassing the Zacks Consensus Estimate by 0.56%, and showing an increase from year-ago revenues of $31.03 million [2] Stock Performance - Quanterix shares have declined approximately 53.8% since the beginning of the year, contrasting with the S&P 500's gain of 9% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.20 on revenues of $36.42 million, and for the current fiscal year, it is -$0.87 on revenues of $141.34 million [7] Industry Outlook - The Medical - Products industry, to which Quanterix belongs, is currently ranked in the top 34% of over 250 Zacks industries, suggesting that companies in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8]